home / stock / lndc / lndc quote
Last: | $8.76 |
---|---|
Change Percent: | 0.77% |
Open: | $9.01 |
Close: | $8.76 |
High: | $9.01 |
Low: | $8.71 |
Volume: | 72,075 |
Last Trade Date Time: | 12/31/1969 07:00:00 pm |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$8.76 | $9.01 | $8.76 | $9.01 | $8.71 | 72,075 | 11-14-2022 |
$9.08 | $9.12 | $9.08 | $9.12 | $8.94 | 57,298 | 11-11-2022 |
$9.03 | $9.01 | $9.03 | $9.08 | $8.84 | 57,039 | 11-10-2022 |
$8.65 | $8.91 | $8.65 | $8.95 | $8.57 | 22,835 | 11-09-2022 |
$8.95 | $9.05 | $8.95 | $9.06 | $8.925 | 32,074 | 11-08-2022 |
$9.03 | $9.03 | $9.03 | $9.18 | $8.95 | 29,440 | 11-07-2022 |
$9.05 | $9.26 | $9.05 | $9.26 | $8.99 | 36,456 | 11-04-2022 |
$9.13 | $9 | $9.13 | $9.25 | $8.97 | 44,025 | 11-03-2022 |
$9.16 | $9.56 | $9.16 | $9.665 | $9.12 | 47,978 | 11-02-2022 |
$9.68 | $9.85 | $9.68 | $9.99 | $9.65 | 48,705 | 11-01-2022 |
$9.95 | $9.86 | $9.95 | $10.5 | $9.8433 | 150,454 | 10-31-2022 |
$9.91 | $9.27 | $9.91 | $10 | $9.21 | 71,251 | 10-28-2022 |
$9.2 | $8.74 | $9.2 | $9.35 | $8.74 | 73,196 | 10-27-2022 |
$8.56 | $8.53 | $8.56 | $8.76 | $8.5 | 48,666 | 10-26-2022 |
$8.48 | $8.13 | $8.48 | $8.66 | $8.13 | 56,287 | 10-25-2022 |
$8.12 | $8.08 | $8.12 | $8.16 | $8.06 | 334,656 | 10-24-2022 |
$8.09 | $8.16 | $8.09 | $8.28 | $8.07 | 43,340 | 10-21-2022 |
$8.09 | $8.14 | $8.09 | $8.15 | $8 | 36,878 | 10-20-2022 |
$8.06 | $8.3 | $8.06 | $8.3 | $8 | 53,114 | 10-19-2022 |
$8.28 | $8.4 | $8.28 | $8.61 | $8.23 | 48,927 | 10-18-2022 |
News, Short Squeeze, Breakout and More Instantly...
CHASKA, Minn., July 01, 2024 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore” or the “Company”), a fully integrated contract development and manufacturing organization (“CDMO”), today announced it has reached a cooperation agreemen...
CHASKA, Minn., May 22, 2024 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore” or the “Company”), a fully integrated contract development and manufacturing organization, today announced that Lifecore has granted a restricted stock unit (“RS...
CHASKA, Minn., May 16, 2024 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore” or the “Company”), a fully integrated contract development and manufacturing organization (“CDMO”), announced certain incremental liquidity measures and h...